Australien -
Englisch -
Department of Health (Therapeutic Goods Administration)
clexane enoxaparin sodium 40mg/0.4ml injection syringe with automatic safety lock system
sanofi-aventis australia pty ltd - enoxaparin sodium, quantity: 40 mg - injection, solution - excipient ingredients: water for injections; nitrogen - prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. prevention of thrombosis in extra-corporeal circulation during haemodialysis. treatment of established deep vein thrombosis. treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin. treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).
Australien -
Englisch -
Department of Health (Therapeutic Goods Administration)
clexane enoxaparin sodium 20mg/0.2ml injection syringe with safety lock system
sanofi-aventis australia pty ltd - enoxaparin sodium, quantity: 20 mg - injection, solution - excipient ingredients: water for injections; nitrogen - prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. prevention of thrombosis in extra-corporeal circulation during haemodialysis. treatment of established deep vein thrombosis. treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin. treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).
Australien -
Englisch -
Department of Health (Therapeutic Goods Administration)
clexane enoxaparin sodium 80mg/0.8ml injection syringe with automatic safety lock system
sanofi-aventis australia pty ltd - enoxaparin sodium, quantity: 80 mg - injection, solution - excipient ingredients: water for injections; nitrogen - prevention of thrombo-embolic disorders of venous origin in patients undergoing orthopaedic and general surgery. prophylaxis of venous thromboembolism in medical patients bedridden due to acute illness. prevention of thrombosis in extra-corporeal circulation during haemodialysis. treatment of established deep vein thrombosis. treatment of unstable angina and non-q-wave myocardial infarction, administered concurrently with aspirin. treatment of acute st-segment elevation myocardial infarction (stemi) as an adjunctive to thrombolytic treatment, including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).
Vereinigtes Königreich -
Englisch -
MHRA (Medicines & Healthcare Products Regulatory Agency)
clexane 40mg/0.4ml solution for injection pre-filled syringes
sanofi - enoxaparin sodium - solution for injection - 100mg/1ml
Vereinigtes Königreich -
Englisch -
MHRA (Medicines & Healthcare Products Regulatory Agency)
clexane 20mg/0.2ml solution for injection pre-filled syringes
sanofi - enoxaparin sodium - solution for injection - 100mg/1ml
Vereinigtes Königreich -
Englisch -
MHRA (Medicines & Healthcare Products Regulatory Agency)
clexane 80mg/0.8ml solution for injection pre-filled syringes
sanofi - enoxaparin sodium - solution for injection - 100mg/1ml
Vereinigtes Königreich -
Englisch -
MHRA (Medicines & Healthcare Products Regulatory Agency)
clexane 60mg/0.6ml solution for injection pre-filled syringes
sanofi - enoxaparin sodium - solution for injection - 100mg/1ml
Neuseeland -
Englisch -
Medsafe (Medicines Safety Authority)
clexane forte
pharmacy retailing (nz) ltd t/a healthcare logistics - enoxaparin sodium 150 mg/ml; - solution for injection - 150 mg/ml - active: enoxaparin sodium 150 mg/ml excipient: water for injection - - treatment of venous thromboembolic disease. - prevention of thrombus formation in the extra-corporeal circulation during haemodialysis.
Malta -
Englisch -
Medicines Authority
clexane inj. sol.10.000 anti-xa iu/1.0ml (100mg/1.0 ml)
sanofi malta limited - enoxaparin sodium - solution for injection - enoxaparin sodium 10 mg/ml - antithrombotic agents
Malta -
Englisch -
Medicines Authority
clexane inj. sol. 2000 anti-xa iu/0.2ml (20mg/0.2 ml)
sanofi malta limited - enoxaparin sodium - solution for injection - enoxaparin sodium 10 mg/ml - antithrombotic agents